Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$682,442
-$342,707 QoQ
Shares Held
3,599
-30.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#763
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $13,218,561 across 10 Drug Manufacturers - General names. AZN ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,918 | $8,297,657 | |
| 2 | ABBV |
AbbVie Inc.
|
5,519 | $1,388,801 | |
| 3 | AMGN |
Amgen Inc
|
3,204 | $1,160,232 | |
| 4 | JNJ |
Johnson & Johnson
|
4,182 | $1,062,102 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
3,599 | $682,442 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,298 | $552,293 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
275 | $34,743 | |
| 8 | NVO |
Novo Nordisk A S
|
428 | $20,518 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $682,442 | 3,599 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,025,149 | 5,198 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||